Autoimmune diseases, of which lupus is but one of many, are essentially black boxes. It’s proven extraordinarily difficult to develop therapies in this area. As such, this is great news. Hopefully this research will encourage pharmaceutical and biotech companies to invest more resources into translating research findings into effective therapies.
I haven’t read the paper yet, so I can’t comment on how this discovery might generalize to other autoimmune diseases, but one interesting bit about autoimmune diseases is that they tend to run in packs. This is suggestive there may be underlying mechanisms that are shared across autoimmune diseases.
I haven’t read the paper yet, so I can’t comment on how this discovery might generalize to other autoimmune diseases, but one interesting bit about autoimmune diseases is that they tend to run in packs. This is suggestive there may be underlying mechanisms that are shared across autoimmune diseases.